Across TCGA pan-cancer cohorts, FAM133FP RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM133FP data layer.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher FAM133FP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM133FP expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.
DLBC, OV, and LUSC are the cancer types where FAM133FP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.